Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 1 year ago AnaIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 1 year ago AnaIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 1 year ago AnaIn Breaking NewsFDA Approvals
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug 1 year ago AnaIn Biopharma HighlightsPartnerships
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease 1 year ago AnaIn Breaking NewsBreakthroughsInnovationTop Stories
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress 1 year ago AnaIn InvestmentsVenture Capital
New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research 1 year ago AnaIn Breaking NewsTop Stories
Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables 1 year ago AnaIn Biopharma Highlights
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis 1 year ago AnaIn Clinical TrialsInnovationTop Stories
Bezuclastinib Delivers Strong Symptom Relief in Systemic Mastocytosis Trial 1 year ago AnaIn Clinical Trials
Rusfertide Meets Key Endpoints in Phase 3 Trial for Polycythemia Vera 1 year ago AnaIn Clinical TrialsResearch Updates
FDA and EMA Approve Phase III Trial of Masitinib Plus Docetaxel for Advanced Prostate Cancer 1 year ago AnaIn FDA ApprovalsResearch UpdatesTop Stories
FDA Gives Accelerated Approval to Lynozyfic for Hard-to-Treat Multiple Myeloma 1 year ago AnaIn FDA ApprovalsResearch UpdatesTop Stories
Breakthroughs and Setbacks: New Data Highlights Promise and Risk in Cell and Gene Therapies 1 year ago AnaIn Biopharma HighlightsPharma Industry Updates
